Emkan Capital is a venture capital firm based in Riyadh, Saudi Arabia, specializing in early-stage technology investments across the Middle East and North Africa (MENA) region. The firm focuses on Seed and Series A funding, aiming to mentor and support technology companies to become global players. Emkan Capital's portfolio includes companies like Hubpay, a licensed cross-border remittance solution, and NovoGenomics, a state-of-the-art genetic testing facility. The firm leverages its extensive network and expertise to provide comprehensive support to its portfolio companies, facilitating their growth and success in the global market.